Literature DB >> 11524393

Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping: Quantitative comparison with thallium-201 uptake.

M Gyöngyösi1, H Sochor, A Khorsand, L Gepstein, D Glogar.   

Abstract

BACKGROUND: The aim of this prospective study was to investigate the concordance between quantitative resting (201)Tl uptake as an established myocardial viability index and the electrical activity of the heart, determined by NOGA nonfluoroscopic electroanatomic mapping. METHODS AND
RESULTS: The myocardial resting and late resting thallium uptakes of 384 myocardial segments from 32 patients (27 males aged 65+/-8 years) with previous myocardial infarction and chronic stable angina were compared with unipolar voltage potentials and local shortening of the left ventricle as assessed by electroanatomic mapping. The quantitative thallium uptake data were analyzed by polar map analysis by division into 12 comparable myocardial segments, as represented in electroanatomic mapping images. Unipolar voltage potentials exhibited a significant logarithmic correlation with both resting and late resting thallium uptake (attenuation corrected: r=0.660 and r=0.744; non-attenuation corrected: r=0.623 and r=0.721). Receiver operator characteristic analyses revealed unipolar voltage cutoff points of 12.0 mV (predictive accuracy 0.853, P< 0.001; sensitivity/specificity 81%) for normal myocardium and 6.4 mV (predictive accuracy 0.901, P< 0.001; sensitivity/specificity 82%) for nonviable myocardium assessed by attenuation-corrected (201)Tl late resting images and of 12.7 mV (predictive accuracy 0.822, P<0.001; sensitivity/specificity 75%) and 6.5 mV (predictive accuracy 0.808, P<0.001; sensitivity/specificity 73%) for non-attenuation-corrected late resting (201)Tl images.
CONCLUSIONS: These results indicate that the unipolar voltage potentials obtained by electroanatomic mapping correlate well with standard quantitative late resting (201)Tl imaging for the evaluation of myocardial viability; thus, NOGA endocardial mapping provides useful "online" data at the time of catheterization, especially when information from other methods for viability assessment is unavailable.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11524393     DOI: 10.1161/hc3401.095099

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  9 in total

Review 1.  Endoventricular electromechanical mapping-the diagnostic and therapeutic utility of the NOGA XP Cardiac Navigation System.

Authors:  Peter J Psaltis; Stephen G Worthley
Journal:  J Cardiovasc Transl Res       Date:  2008-12-10       Impact factor: 4.132

2.  Validation of transcatheter left ventricular electromechanical mapping for assessment of cardiac function and targeted transendocardial injection in a porcine ischemia-reperfusion model.

Authors:  Sharven Taghavi; Jason M Duran; Remus M Berretta; Catherine A Makarewich; Foram Udeshi; Thomas E Sharp; Hajime Kubo; Steven R Houser; Jon C George
Journal:  Am J Transl Res       Date:  2012-04-18       Impact factor: 4.060

Review 3.  The role of integrated PET-CT scar maps for guiding ventricular tachycardia ablations.

Authors:  Timm Dickfeld; Christopher Kocher
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

4.  Hypoxia-inducible factor 1-alpha release after intracoronary versus intramyocardial stem cell therapy in myocardial infarction.

Authors:  Mariann Gyöngyösi; Rayyan Hemetsberger; Aniko Posa; Silvia Charwat; Noemi Pavo; Ors Petnehazy; Zsolt Petrasi; Imre J Pavo; Hani Hemetsberger; Imre Benedek; Teodora Benedek; Istvan Benedek; Istvan Kovacs; Christoph Kaun; Gerald Maurer
Journal:  J Cardiovasc Transl Res       Date:  2009-12-23       Impact factor: 4.132

Review 5.  Diagnostic and prognostic value of 3D NOGA mapping in ischemic heart disease.

Authors:  Mariann Gyöngyösi; Nabil Dib
Journal:  Nat Rev Cardiol       Date:  2011-05-17       Impact factor: 32.419

6.  [Long-term results of percutaneous transmyocardial laser revascularization therapy at the University of Vienna Medical Center].

Authors:  Melanie Gatterer; Mariann Gyöngyösi; Wolfgang Sperker; Christoph Strehblow; Aliasghar Khorsand; Senta Graf; Heinz Sochor; Dietmar Glogar
Journal:  Wien Klin Wochenschr       Date:  2004-04-30       Impact factor: 1.704

7.  Serial noninvasive in vivo positron emission tomographic tracking of percutaneously intramyocardially injected autologous porcine mesenchymal stem cells modified for transgene reporter gene expression.

Authors:  Mariann Gyöngyösi; Jeronimo Blanco; Teréz Marian; Lajos Trón; Ors Petneházy; Zsolt Petrasi; Rayyan Hemetsberger; Julio Rodriguez; Gusztáv Font; Imre J Pavo; István Kertész; László Balkay; Noemi Pavo; Aniko Posa; Miklos Emri; László Galuska; Dara L Kraitchman; Johann Wojta; Kurt Huber; Dietmar Glogar
Journal:  Circ Cardiovasc Imaging       Date:  2008-07-30       Impact factor: 7.792

8.  Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study.

Authors:  Mariann Gyöngyösi; Irene Lang; Markus Dettke; Gilbert Beran; Senta Graf; Heinz Sochor; Noémi Nyolczas; Silvia Charwat; Rayyan Hemetsberger; Günter Christ; István Edes; László Balogh; Korff Thomas Krause; Kai Jaquet; Karl-Heinz Kuck; Imre Benedek; Theodora Hintea; Róbert Kiss; István Préda; Vladimir Kotevski; Hristo Pejkov; Sholeh Zamini; Aliasghar Khorsand; Gottfried Sodeck; Alexandra Kaider; Gerald Maurer; Dietmar Glogar
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-11-11

9.  Comparison of NOGA endocardial mapping and cardiac magnetic resonance imaging for determining infarct size and infarct transmurality for intramyocardial injection therapy using experimental data.

Authors:  Noemi Pavo; Andras Jakab; Maximilian Y Emmert; Georg Strebinger; Petra Wolint; Matthias Zimmermann; Hendrik Jan Ankersmit; Simon P Hoerstrup; Gerald Maurer; Mariann Gyöngyösi
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.